DAAs for HCV Infection and Risk of Incident Liver Cancer DAAs for HCV Infection and Risk of Incident Liver Cancer

Does DAA-based HCV treatment reduce the risk of incident liver cancer compared to untreated HCV or interferon-based treatment?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news